Companies

Arvinas

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

Pharmaceutical Executive

Pharmaceutical Executive · May 13, 2026

Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu

Co-licensor of Vepanu with Pfizer; receives $70M upfront plus milestone payments and royalties

PROTAC Technology and Protein DegradationCancer Therapy InnovationGLP-1 Receptor Agonist Therapies
View Analysis